New Zealand markets closed

Hangzhou Tigermed Consulting Co., Ltd (3347.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
27.600-1.000 (-3.50%)
At close: 04:08PM HKT
Full screen
Previous close28.600
Open28.600
Bid27.550 x N/A
Ask27.650 x N/A
Day's range27.500 - 29.000
52-week range22.100 - 52.550
Volume1,001,522
Avg. volume1,693,871
Market cap40.931B
Beta (5Y monthly)0.73
PE ratio (TTM)13.14
EPS (TTM)2.100
Earnings date23 Aug 2024 - 27 Aug 2024
Forward dividend & yield0.62 (2.18%)
Ex-dividend date07 Jun 2024
1y target est48.83
  • Zacks

    Veeva Systems' (VEEV) Vault EDC to Boost Tigermed's Workflow

    Veeva Systems' (VEEV) Vault EDC is likely to streamline key processes to accelerate study builds and make mid-study amendments with no downtime.

  • PR Newswire

    Tigermed Reports Full Year 2023 Results

    Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023 (the "Reporting Period").